Literature DB >> 7408938

Enhancement of the primary antibody response by 2-mercaptoethanol is mediated by its action on glutathione in the serum.

J T Hoffeld, J J Oppenheim.   

Abstract

2-Mercaptoethanol (2-ME) is widely used in rodent lymphoid cell cultures as an enhancer of multiple cellular functions. We have confirmed that the action of 2-ME must be on a serum component(s), rather than a direct action on the cells. The serum component(s) is contained within the dialyzable fraction of fetal calf serum (FCS) since: (a) dialysis of FCS diminished the ability of FCS to support an antibody response even in the presence of 2-ME; and (b) FCS dialysate, pulsed with 2-ME, restored the ability of dialyzed FCS to support an antibody response. Diminution of the reduced glutathione content of FCS by heating reduced the capacity of FCS to support an antibody response, whereas addition of 2-ME-pulsed glutathione restored the supportive capacity of heated FCS. Conversely, oxidized glutathione inhibited the antibody response in the absence of 2-ME, but that inhibition was not seen in the presence of 2-ME. We have concluded that reduced glutathione is an essential component in FCS in order for 2-ME to produce its enhancing effect. The most plausible explanation for the enhancement of antibody responses, in vitro, by 2-ME, is the concomitant reversal of the inhibitory effect of oxidized glutathione and the increased availability of reduced glutathione which can scavenge oxygen-derived radicals, thus protecting macrophages and lymphocytes from the deleterious effects of oxygen-derived free radicals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7408938     DOI: 10.1002/eji.1830100514

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Substitution of transferrin by FeCl3 in the development of a low foetal calf serum concentration medium for KB-26.5 hybridoma cell line.

Authors:  B Damgaard; A Sanfeliu; J J Cairó; C Casas; C Solà; F Gòdia
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

2.  Serum substitute in epithelial cell culture media: nonfat dry milk filtrate.

Authors:  A C Fassolitis; R M Novelli; E P Larkin
Journal:  Appl Environ Microbiol       Date:  1981-08       Impact factor: 4.792

3.  Obesity, longevity, quality of life: alteration by dietary 2-mercaptoethanol.

Authors:  Robert E Click
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

4.  Mercaptoethanol protects glutathione depleted cells.

Authors:  P C Chen; E Gaetjens; J D Broome
Journal:  Agents Actions       Date:  1987-10

5.  Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment.

Authors:  K J Holroyd; R Buhl; Z Borok; J H Roum; A D Bokser; G J Grimes; D Czerski; A M Cantin; R G Crystal
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

6.  Differential requirements for rabbit dendritic cells and macrophages in T lymphocyte proliferation induced by various mitogens.

Authors:  M L Kapsenberg; F Stiekema; W Leene
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

7.  Role of activation in alveolar macrophage-mediated suppression of the plaque-forming cell response.

Authors:  I N Mbawuike; H B Herscowitz
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

8.  2-Mercaptoethanol and n-acetylcysteine enhance T cell colony formation in AIDS and ARC.

Authors:  J Wu; E M Levy; P H Black
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

9.  Mechanism of augmentation of the antibody response in vitro by 2-mercaptoethanol in murine lymphocytes. I. 2-Mercaptoethanol-induced stimulation of the uptake of cystine, an essential amino acid.

Authors:  H Ohmori; I Yamamoto
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

10.  Antibody production in cultured blood lymphocytes from breast cancer patients.

Authors:  M L Villa; M Migliori; E Clerici
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.